Similar Articles |
|
BusinessWeek December 6, 2004 Catherine Arnst |
Cord Blood To The Rescue A study in the Nov. 25 issue of The New England Journal of Medicine confirms that stem cells in blood extracted from the umbilical cords of newborns can help leukemia patients |
BusinessWeek June 27, 2005 Arlene Weintraub |
Stem Cells To Go ViaCell's goal is to mass-produce stem cells from umbilical cord blood. |
The Motley Fool November 30, 2004 Rich Smith |
Breaking Rules and Saving Lives Cord blood offers an ethical means of using stem cells to heal illness. While two top companies in the field are private, over the counter traded Cryo-Cell lost as much money as it collected in revenues last year. |
HHMI Bulletin May 2010 Sarah C.P. Williams |
Young Again Niche cells can reverse the aging of stem cells. |
Popular Mechanics December 16, 2008 Michael Milstein |
Bringing Stem Cells to War: Meet the Blood Pharmers Fresher blood is better than stale: It carries more oxygen and, when transfused into patients, speeds recovery. |
BusinessWeek May 24, 2004 Arlene Weintraub |
Want To Bank Your Own Stem Cells? One Los Angeles startup believes everyone should, to be ready when regenerative therapies start hitting the market |
Popular Mechanics January 28, 2010 Cassie Rodenberg |
Next-Gen Transplant Techniques Can Stop Organ Rejection About 77 organ transplants are performed each day in the U.S., and more than 101,000 people are on a wait list for body parts such as hearts, skin and veins, according to the Mayo Clinic. |
The Motley Fool September 20, 2005 Rich Smith |
ViaCell's Cancer Trial Snag The cord blood collector suffers a research setback. Investors should keep in mind that the real money-maker behind ViaCell is its ViaCord cord blood storage business. |
The Motley Fool November 9, 2004 Charly Travers |
Are Stem Cells a Rule Breaker? Does the science offer real hope or just hype? Biotech investors take on enough risk in the normal course of drug development that they do not need to worry about whether or not the underlying technology even works. |
BusinessWeek February 12, 2007 Bruce Einhorn |
Stem-Cell Refugees Americans are flocking to China for therapy. |
The Motley Fool February 23, 2007 Rich Smith |
Foolish Forecast: ViaCell Doing Well? The cord blood specialist is set to report its fourth-quarter and full-year 2006 numbers shortly. Investors, here is what you can expect to see. |
The Motley Fool August 31, 2007 Brian Orelli |
A Stem-Cell Primer Public funding from states could help companies doing stem cell research. Read about Geron, StemCells, Osiris Therapeutics, ViaCell and Invitrogen, companies that may profit from the increased public spending. |
Chemistry World December 18, 2013 Sarah Kenwright |
Excess glucose limits blood transfusion success Reducing the level of glucose in solutions used to process blood donations could benefit patients receiving blood transfusions, new research shows. |
Salon.com October 5, 2000 Leah Kohlenberg |
Designer babies? Pediatrician and ethicist Joel Frader says that just because a family has had a child to provide a bone-marrow transplant for an ailing daughter, it doesn't mean custom-ordered kids are right around the corner... |
BusinessWeek June 13, 2005 Arlene Weintraub |
A Boost for Broken Hearts? The Institute of Regenerative Medicine in Barbados is convinced that stem cells from fetuses can repair cardiac damage. |
The Motley Fool April 30, 2007 Mike Havrilla |
ThermoGenesis Is Ready to Heat Up Shares of ThermoGenesis are currently trading at compelling levels that could produce nice gains if the company receives FDA approvals and subsequently ramps up the sales of its umbilical cord blood stem cell processing machines and ancillary products. |
HHMI Bulletin May 2012 Sarah C. P. Williams |
Stephen Quake: Innovative Thinking on Genetic Tests His ideas have already led to a blood test to tell a pregnant woman whether her fetus has Down syndrome. Now, the HHMI investigator is pushing further, to track the success of heart transplants and diagnose autoimmune diseases and allergies. |
Popular Mechanics November 27, 2007 Alex Hutchinson |
Stem Cells 2.0: Beyond the Hype, Engineers Look to Build Fast Engineers play the important role of making lab bench discoveries reproducible and efficient for use in industry. |
Scientific American January 2009 Charles Q. Choi |
Do White Blood Cells Make Cancer Deadly? The ability to spread underlies the killing power of cancer. The process occurs, John Pawelek thinks, when tumor cells fuse with white blood cells -- an idea that, if right, could yield new therapies |
Chemistry World October 2010 |
Artificial blood Synthetic alternatives to donor blood have been stuck in development for decades. Nina Notman reports on recent promising progress |
Salon.com August 21, 2000 Lori B. Andrews |
Embryos under the knife The latest reproductive technology is just the next step on our sprint toward human cloning. |
BusinessWeek February 10, 2011 Rob Waters |
Sangamo's Bet Against AIDS: Gene Therapy Sangamo's stock has more than doubled since July 6, when the company, with no products on the market, reported success of its gene therapy approach in mice in the journal Nature Biotechnology. |
Bio-IT World Dec 2005/Jan 2006 Maureen McDonough |
The Century of the Cell Like most new life science industries, the stem cell business landscape looks like a maze. There are many paths, turns, and dead-ends, but it is quite possible that there will be more than one route to the finish line. |
Pharmaceutical Executive October 1, 2012 Ben Comer |
Stem Cells: A Promise Deferred? Ideology, politics, and a stilted political debate may be causing pharma to overlook the potential of emerging stem cell therapies in fostering a new generation of cures. |
The Motley Fool July 23, 2007 Brian Lawler |
Acquisitive Ways Paying Off for Genzyme A recently acquired drug yields positive study results. Genzyme investors, take note. |
Fast Company March 2009 Tim McKeough |
Banking Stem Cells For Future Use A personal banking system for stem cells. |
Salon.com September 5, 2001 Lisa Moricoli Latham |
What are we fighting for? I just lost a pregnancy, but gained new insight into the stem cell debate... |
Popular Mechanics January 2010 Amber Angelle |
How to Create a Designer Baby Women undergoing in vitro fertilization could one day choose to have a baby boy with perfect vision, an aptitude for sports and a virtual lock on avoiding colon cancer. |
Scientific American November 2005 Charles Q. Choi |
Baby to Brain Mothers could literally always have their kids on their minds. Researchers find that in mice, cells from fetuses can migrate into a mother's brain and apparently develop into nervous system cells. |
Reason July 2004 Caroline Waters |
Bloody Shame Unnecessary regulations are making American blood banks run dry. |
Chemistry World May 4, 2010 Lewis Brindley |
Blood type testing for a few pence 'Our technique prints a microfluidic circuit containing the three antibodies (A, B and D) directly onto paper,' says Gil Garnier, who led the research at Monash University in Melbourne. |
The Motley Fool April 3, 2006 Seth Jayson |
No Stemming the Flow of Shares Another year, another large dollop of shares to water down the juice at StemCells. This company excels at burning money, as its cash flow statements show. Invest accordingly. |
Bio-IT World October 14, 2004 |
Stem Cells and the Ballot Box Science policy is seldom a pivotal factor in U.S. presidential elections, but this year might be an exception. |
Chemistry World August 28, 2012 Andrew Turley |
Myelofibrosis drug approved in EU Jakavi (ruxolitinib) tablets have been approved in the EU for the treatment of myelofibrosis, a rare disease affecting the bone marrow. |
Chemistry World July 30, 2007 James Mitchell Crow |
Cell Transplant Hope for Diabetes Sufferers Iron-based 'magnetocapsules' of insulin-producing cells could help doctors use cell transplants to treat type I diabetes. |
Chemistry World March 22, 2011 Amaya Camara-Campos |
Microfluidics to diagnose sleeping sickness Jonas Tegenfeldt from the University of Lund developed a microfluidic device that separates the parasites in this disease from the blood cells using their shape, because parasites and red blood cells are very difficult to separate by size. |
Reason October 2001 Ronald Bailey |
Blastocyst Brouhaha Which human cells count as people? |
The Motley Fool November 8, 2005 Rich Smith |
ViaCell Looks Healthier The cord blood collector reports narrowing losses. Investors, take note. |
Wired January 2003 Charles C. Mann |
The First Cloning Superpower Inside China's race to become the clone capital of the world. |
Scientific American April 2009 Philip Yam |
Updates: Whatever Happened to Melting Glaciers and Ocean Levels? New details are emerging on how the melting poles could raise ocean heights... Fingerprint science... Stem cell progress... The far side of the moon... |
HHMI Bulletin May 2011 Jim Schnabel |
Oxygen on the Brain An ancient cellular program to protect cells when oxygen is low seems crucial for the production of new brain cells. |
Salon.com December 29, 2000 Arthur Allen |
Will Thompson, Bush clash over human embryo research? The HHS nominee supports it, but right-to-lifers want it stopped.... |
Health May 18, 2009 Hallie Levine Sklar |
Babies After 40: The Hidden Health Risks of Mid-Life Pregnancy The number of women giving birth into their 40s and 50s and beyond is at record highs |
Scientific American March 2009 Elaine Schattner |
A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment |
The Motley Fool August 16, 2007 Jack Uldrich |
Intel Has RFID Technology in Its Blood A new blood bank RFID program in Malaysia could lead to big opportunities for investors. |
Reactive Reports Issue 64 David Bradley |
Stem to Sperm New research shows that stem cells from human bone marrow can be converted into early-stage sperm. The discovery could lead to novel fertility treatments in the long-term. |
Chemistry World February 9, 2012 Harriet Brewerton |
Pressurizing red blood cells for information Scientists in Canada have developed a method to study the changes in red blood cells caused by the most common malaria parasite Plasmodium falciparum. |
BusinessWeek September 23, 2010 Rob Waters |
Stem Cells That Save Big Pharma a Bundle Drugmakers hope to save big by using stem cells to test drugs for dangerous side effects long before costly human trials are needed. |
American Family Physician June 1, 2006 |
High Blood Pressure: What You Should Know A patient guide: What is high blood pressure?... What if I have heart or kidney problems or diabetes?... What can I do to help lower my blood pressure?... etc. |
Chemistry World October 8, 2007 Michael Gross |
Blood Transfusion Risk Explained Two research groups have discovered that nitric oxide disappears rapidly from banked blood -- a finding that may explain recent medical studies showing that blood transfusions can sometimes increase a patient's chances of dying from a lack of oxygen. |